Literature DB >> 7077081

Ultrastructure of human natural killer cells: nature of the cytolytic contacts in relation to cellular secretion.

O Carpen, I Virtanen, E Saksela.   

Abstract

The ultrastructure of human NK cells, NK/target cell conjugates, and the effect of monensin, a secretion inhibitor, were studied. Human peripheral blood lymphocytes, highly enriched (75 to 85%) in large granular lymphocytes (LGL), which are known to be the mediators of human NK activity, were used as effectors, and K562 cells as targets. LGL-type of cells were characterized in electron microscopy by a low nucleocytoplasmic ratio, indented nucleus, several large mitochondria, prominent Golgi apparatus, and cytoplasmic osmiophilic granules bound by a unit membrane. Their surface was of intermediate villous type. Two types of effector/target contacts were seen: either effector cell protrusions were pushed deep into pouches and lacunae of the target cell surface, or a wide area of intimate cell-to-cell contact was formed. The contact formation was followed by polarization of the effector cell Golgi apparatus towards the contact area. Monensin, a carboxylic ionophore, which interrupts the vesicular traffic of Golgi-derived vacuoles to the cell surface, caused an accumulation of cytoplasmic vesicles in the LGL but had no effect on the effector/target contact formation. Monensin inhibited the NK lysis apparently via cessation of secretion by the LGL. It did not affect the viability of the effector cells. The lytic steps of human NK cells thus involve binding to the target cell, polarization of cytoplasmic organelles towards the target, and apparently a precisely directed exocytosis of secretory material.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7077081

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

Review 1.  Cytotoxic immunological synapses.

Authors:  Michael L Dustin; Eric O Long
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  Functional surface structures on human natural killer cells.

Authors:  R E Schmidt; T Hercend; S F Schlossman; J Ritz
Journal:  Klin Wochenschr       Date:  1985-12-02

Review 3.  Natural killer cell activation by dendritic cells: balancing inhibitory and activating signals.

Authors:  Rosa Barreira da Silva; Christian Münz
Journal:  Cell Mol Life Sci       Date:  2011-08-23       Impact factor: 9.261

4.  Purification and characterization of cytolytic and noncytolytic human natural killer cell subsets.

Authors:  L T Lebow; B Bonavida
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

Review 5.  Formation and function of the lytic NK-cell immunological synapse.

Authors:  Jordan S Orange
Journal:  Nat Rev Immunol       Date:  2008-09       Impact factor: 53.106

6.  Molecular cloning of an inducible serine esterase gene from human cytotoxic lymphocytes.

Authors:  J A Trapani; J L Klein; P C White; B Dupont
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

7.  In vitro binding of natural killer cells to Cryptococcus neoformans targets.

Authors:  N Nabavi; J W Murphy
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

8.  Localization and characterization of T-cell subpopulations and natural killer cells (HNK 1+ cells) in the human tonsilla palatina. An ultrastructural-immunocytochemical study.

Authors:  B von Gaudecker; U Pfingsten; H K Müller-Hermelink
Journal:  Cell Tissue Res       Date:  1984       Impact factor: 5.249

9.  Antibody- and interferon-dependent killer cells are part of the NK cell receptor positive subpopulation of human peripheral blood cells.

Authors:  M Ullberg; M Jondal
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

10.  Natural killer cell signal integration balances synapse symmetry and migration.

Authors:  Fiona J Culley; Matthew Johnson; J Henry Evans; Sunil Kumar; Rupert Crilly; Juan Casasbuenas; Tim Schnyder; Maryam Mehrabi; Mahendra P Deonarain; Dmitry S Ushakov; Veronique Braud; Günter Roth; Roland Brock; Karsten Köhler; Daniel M Davis
Journal:  PLoS Biol       Date:  2009-07-28       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.